Molecular Methods Market by Product Type and Technology - Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 157 Category: Biotechnology Report Code : HC0114748
Molecular Methods Market By Product Type (Reagents & Consumables, Instruments, Services), Technology (Polymerase Chain Reaction (PCR), Immunoassay, Biosensors, Microarray, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Molecular Methods Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Molecular Methods plays important role in understanding formations, actions, and regulations of various parts of cells which can be used to efficiently target new drugs, diagnose disease, and understand the physiology of the cell.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Molecular Methods Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- QIAGEN
- 3M
- Veredus Laboratories
- NEOGEN CORPORATION
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- HiMedia Laboratories
- Eurofins Scientific
- SGS SA
- Agilent Technologies, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Molecular Methods Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Reagents & Consumables
o Instruments
o Service
· Molecular Methods Market, ByTechnology, Estimates and Forecast, 2017-2027 ($Million)
o Polymerase Chain Reaction (PCR)
o Immunoassay
o Biosensors
o Microarray
o Others
· Molecular Methods Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o QIAGEN
o 3M
o Veredus Laboratories
o NEOGEN CORPORATION
o Bio-Rad Laboratories, Inc.
o Thermo Fisher Scientific, Inc.
o HiMedia Laboratories
o Eurofins Scientific
o SGS SA
· Molecular Methods Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Molecular Methods Market, By Country
o U.S. Molecular Methods Market
o Canada Molecular Methods Market
o Mexico Molecular Methods Market
o Europe
§ Europe Molecular Methods Market, By Country
o UK Molecular Methods Market
o Germany Molecular Methods Market
o France Molecular Methods Market
o Russia Molecular Methods Market
o Italy Molecular Methods Market
o Rest of Europe Molecular Methods Market
o Asia-Pacific
§ Asia-Pacific Molecular Methods Market, By Country
o China Molecular Methods Market
o Japan Molecular Methods Market
o South Korea Molecular Methods Market
o India Molecular Methods Market
o Southeast Asia Molecular Methods Market
o Rest of Asia-Pacific Molecular Methods Market
o South America
§ South America Molecular Methods Market
o Brazil Molecular Methods Market
o Argentina Molecular Methods Market
o Columbia Molecular Methods Market
o Rest of South America Molecular Methods Market
o Middle East and Africa
§ Middle East and Africa Molecular Methods Market
o Saudi Arabia Molecular Methods Market
o UAE Molecular Methods Market
o Egypt Molecular Methods Market
o Nigeria Molecular Methods Market
o South Africa Molecular Methods Market
o TurkeyMolecular Methods Market
o Rest of MEA Molecular Methods Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Molecular Methods Market, By Product Type
5.1. Introduction
5.2. Global Molecular Methods Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Molecular Methods Revenue and Revenue Share by Product Type (2017-2021)
5.3. Reagents & Consumables
5.3.1. Global Reagents & Consumables Revenue and Growth Rate (2017-2021)
5.4. Instruments
5.4.1. Global Instruments Revenue and Growth Rate (2017-2021)
5.5. Service
5.5.1. Global Service Revenue and Growth Rate (2017-2021)
6. Molecular Methods Market, By Technology
6.1. Introduction
6.2. Global Molecular Methods Revenue and Market Share by Technology (2017-2021)
6.2.1. Global Molecular Methods Revenue and Revenue Share by Technology (2017-2021)
6.3. Polymerase Chain Reaction (PCR)
6.3.1. Global Polymerase Chain Reaction (PCR) Revenue and Growth Rate (2017-2021)
6.4. Immunoassay
6.4.1. Global Immunoassay Revenue and Growth Rate (2017-2021)
6.5. Biosensors
6.5.1. Global Biosensors Revenue and Growth Rate (2017-2021)
6.6. Microarray
6.6.1. Global Microarray Revenue and Growth Rate (2017-2021)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2021)
7. Molecular Methods Market, By Region
7.1. Introduction
7.2. Global Molecular Methods Revenue and Market Share by Regions
7.2.1. Global Molecular Methods Revenue by Regions (2017-2021)
7.3. North America Molecular Methods by Countries
7.3.1. North America Molecular Methods Revenue and Growth Rate (2017-2021)
7.3.2. North America Molecular Methods Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Molecular Methods by Countries
7.4.1. Europe Molecular Methods Revenue and Growth Rate (2017-2021)
7.4.2. Europe Molecular Methods Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Molecular Methods by Countries
7.5.1. Asia-Pacific Molecular Methods Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Molecular Methods Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Molecular Methods by Countries
7.6.1. South America Molecular Methods Revenue and Growth Rate (2017-2021)
7.6.2. South America Molecular Methods Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Molecular Methods by Countries
7.7.1. Middle East and Africa Molecular Methods Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Molecular Methods Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. QIAGEN
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. 3M
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Veredus Laboratories
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. NEOGEN CORPORATION
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bio-Rad Laboratories, Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Thermo Fisher Scientific, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. HiMedia Laboratories
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Eurofins Scientific
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. SGS SA
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Agilent Technologies, Inc
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Molecular Methods Market Forecast (2022-2027)
9.1. Global Molecular Methods Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Molecular Methods Market Forecast by Regions (2022-2027)
9.2.1. North America Molecular Methods Market Forecast (2022-2027)
9.2.1.1. United States Molecular Methods Market Forecast (2022-2027)
9.2.1.2. Canada Molecular Methods Market Forecast (2022-2027)
9.2.1.3. Mexico Molecular Methods Market Forecast (2022-2027)
9.2.2. Europe Molecular Methods Market Forecast (2022-2027)
9.2.2.1. Germany Molecular Methods Market Forecast (2022-2027)
9.2.2.2. France Molecular Methods Market Forecast (2022-2027)
9.2.2.3. UK Molecular Methods Market Forecast (2022-2027)
9.2.2.4. Russia Molecular Methods Market Forecast (2022-2027)
9.2.2.5. Italy Molecular Methods Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Molecular Methods Market Forecast (2022-2027)
9.2.3. Asia-Pacific Molecular Methods Market Forecast (2022-2027)
9.2.3.1. China Molecular Methods Market Forecast (2022-2027)
9.2.3.2. Japan Molecular Methods Market Forecast (2022-2027)
9.2.3.3. Korea Molecular Methods Market Forecast (2022-2027)
9.2.3.4. India Molecular Methods Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Molecular Methods Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Molecular Methods Market Forecast (2022-2027)
9.2.4. South America Molecular Methods Market Forecast (2022-2027)
9.2.4.1. Brazil Molecular Methods Market Forecast (2022-2027)
9.2.4.2. Argentina Molecular Methods Market Forecast (2022-2027)
9.2.4.3. Columbia Molecular Methods Market Forecast (2022-2027)
9.2.4.4. Rest of South America Molecular Methods Market Forecast (2022-2027)
9.2.5. Middle East and Africa Molecular Methods Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Molecular Methods Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Molecular Methods Market Forecast (2022-2027)
9.2.5.3. Egypt Molecular Methods Market Forecast (2022-2027)
9.2.5.4. Nigeria Molecular Methods Market Forecast (2022-2027)
9.2.5.5. South Africa Molecular Methods Market Forecast (2022-2027)
9.2.5.6. Turkey Molecular Methods Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Molecular Methods Market Forecast (2022-2027)
9.3. Molecular Methods Market Forecast by Product Type (2022-2027)
9.3.1. Molecular Methods Forecast by Product Type (2022-2027)
9.3.2. Molecular Methods Market Share Forecast by Product Type (2022-2027)
9.4. Molecular Methods Market Forecast by Technology (2022-2027)
9.4.1. Molecular Methods Forecast by Technology (2022-2027)
9.4.2. Molecular Methods Market Share Forecast by Technology (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Molecular Methods Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Molecular Methods Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Reagents & Consumables Revenue and Growth Rate (2017-2019)
Figure Global Instruments Revenue and Growth Rate (2017-2019)
Figure Global Service Revenue and Growth Rate (2017-2019)
Table Global Molecular Methods Revenue and Revenue Share by Technology (2017-2019)
Figure Global Polymerase Chain Reaction (PCR) Revenue and Growth Rate (2017-2019)
Figure Global Immunoassay Revenue and Growth Rate (2017-2019)
Figure Global Biosensors Revenue and Growth Rate (2017-2019)
Figure Global Microarray Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Molecular Methods Revenue by Regions (2017-2019)
Figure North America Molecular Methods Growth Rate (2017-2019)
Figure North America Molecular Methods Revenue and Growth Rate (2017-2019)
Figure North America Molecular Methods by Countries (2017-2019)
Figure North America Molecular Methods Revenue (Million USD) by Countries (2017-2019)
Figure United States Molecular Methods Growth Rate (2017-2019)
Figure United States Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Molecular Methods Growth Rate (2017-2019)
Figure Canada Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Molecular Methods Growth Rate (2017-2019)
Figure Mexico Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Molecular Methods Growth Rate (2017-2019)
Figure Europe Molecular Methods Revenue and Growth Rate (2017-2019)
Figure Europe Molecular Methods by Countries (2017-2019)
Figure Europe Molecular Methods Revenue (Million USD) by Countries (2017-2019)
Figure Germany Molecular Methods Growth Rate (2017-2019)
Figure Germany Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Molecular Methods Growth Rate (2017-2019)
Figure France Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Molecular Methods Growth Rate (2017-2019)
Figure UK Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Molecular Methods Growth Rate (2017-2019)
Figure Russia Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Molecular Methods Growth Rate (2017-2019)
Figure Italy Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Molecular Methods Growth Rate (2017-2019)
Figure Rest of Europe Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Molecular Methods Growth Rate (2017-2019)
Figure Asia-Pacific Molecular Methods Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Molecular Methods by Countries (2017-2019)
Figure Asia-Pacific Molecular Methods Revenue (Million USD) by Countries (2017-2019)
Figure China Molecular Methods Growth Rate (2017-2019)
Figure China Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Molecular Methods Growth Rate (2017-2019)
Figure Japan Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Molecular Methods Growth Rate (2017-2019)
Figure Korea Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Molecular Methods Growth Rate (2017-2019)
Figure India Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Molecular Methods Growth Rate (2017-2019)
Figure Southeast Asia Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Molecular Methods Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Molecular Methods Growth Rate (2017-2019)
Figure South America Molecular Methods Revenue and Growth Rate (2017-2019)
Figure South America Molecular Methods by Countries (2017-2019)
Figure South America Molecular Methods Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Molecular Methods Growth Rate (2017-2019)
Figure Brazil Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Molecular Methods Growth Rate (2017-2019)
Figure Argentina Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Molecular Methods Growth Rate (2017-2019)
Figure Columbia Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Molecular Methods Growth Rate (2017-2019)
Figure Rest of South America Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Molecular Methods Growth Rate (2017-2019)
Figure Middle East and Africa Molecular Methods Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Molecular Methods by Countries (2017-2019)
Figure Middle East and Africa Molecular Methods Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Molecular Methods Growth Rate (2017-2019)
Figure Saudi Arabia Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Molecular Methods Growth Rate (2017-2019)
Figure United Arab Emirates Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Molecular Methods Growth Rate (2017-2019)
Figure Egypt Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Molecular Methods Growth Rate (2017-2019)
Figure Nigeria Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Molecular Methods Growth Rate (2017-2019)
Figure South Africa Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Molecular Methods Growth Rate (2017-2019)
Figure Turkey Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Molecular Methods Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Molecular Methods Revenue (Millions USD) and Growth Rate (2017-2019)
Table QIAGEN Molecular Methods Financial Overview
Table 3M Molecular Methods Financial Overview
Table Veredus Laboratories Molecular Methods Financial Overview
Table NEOGEN CORPORATION Molecular Methods Financial Overview
Table Bio-Rad Laboratories, Inc. Molecular Methods Financial Overview
Table Thermo Fisher Scientific, Inc. Molecular Methods Financial Overview
Table HiMedia Laboratories Molecular Methods Financial Overview
Table Eurofins Scientific Molecular Methods Financial Overview
Table SGS SA Molecular Methods Financial Overview
Table Agilent Technologies, Inc Molecular Methods Financial Overview
Figure Global Molecular Methods Revenue (Millions USD) and Growth Rate (2019-2027)
Table Molecular Methods Market Forecast by Regions (2019-2027)
Figure North America Molecular Methods Market Forecast (2019-2027)
Figure United States Molecular Methods Market Forecast (2019-2027)
Figure Canada Molecular Methods Market Forecast (2019-2027)
Figure Mexico Molecular Methods Market Forecast (2019-2027)
Figure Europe Molecular Methods Market Forecast (2019-2027)
Figure Germany Molecular Methods Market Forecast (2019-2027)
Figure France Molecular Methods Market Forecast (2019-2027)
Figure UK Molecular Methods Market Forecast (2019-2027)
Figure Russia Molecular Methods Market Forecast (2019-2027)
Figure Italy Molecular Methods Market Forecast (2019-2027)
Figure Rest of Europe Molecular Methods Market Forecast (2019-2027)
Figure Asia-Pacific Molecular Methods Market Forecast (2019-2027)
Figure China Molecular Methods Market Forecast (2019-2027)
Figure Japan Molecular Methods Market Forecast (2019-2027)
Figure Korea Molecular Methods Market Forecast (2019-2027)
Figure India Molecular Methods Market Forecast (2019-2027)
Figure Southeast Asia Molecular Methods Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Molecular Methods Market Forecast (2019-2027)
Figure South America Molecular Methods Market Forecast (2019-2027)
Figure Brazil Molecular Methods Market Forecast (2019-2027)
Figure Argentina Molecular Methods Market Forecast (2019-2027)
Figure Columbia Molecular Methods Market Forecast (2019-2027)
Figure Rest of South America Molecular Methods Market Forecast (2019-2027)
Figure Middle East and Africa Molecular Methods Market Forecast (2019-2027)
Figure Saudi Arabia Molecular Methods Market Forecast (2019-2027)
Figure United Arab Emirates Molecular Methods Market Forecast (2019-2027)
Figure Egypt Molecular Methods Market Forecast (2019-2027)
Figure Nigeria Molecular Methods Market Forecast (2019-2027)
Figure South Africa Molecular Methods Market Forecast (2019-2027)
Figure Turkey Molecular Methods Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Molecular Methods Market Forecast (2019-2027)
Figure Global Molecular Methods Forecast by Product Type (2019-2027)
Figure Global Molecular Methods Market Share Forecast by Product Type (2019-2027)
Figure Global Molecular Methods Forecast by Product Type (2019-2027)
Figure Global Molecular Methods Forecast by Technology (2019-2027)
Figure Global Molecular Methods Market Share Forecast by Technology (2019-2027)
Figure Global Molecular Methods Forecast by Technology (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|